한글목차

세계 C형 간염 바이러스(HCV) 검사 시장 규모는 인지도 향상, 진단 기술 발전, 적극적인 헬스케어 이니셔티브에 힘입어 꾸준히 성장하고 있습니다. 2025년까지 8억 9,400만 달러에 달할 것으로 예상되며, 2032년까지 13억 2,670만 달러로 증가할 것으로 예상되며, CAGR은 5.80%로 예상됩니다.

시장 개요 HCV 검사는 전 세계 보건 문제인 C형 간염 감염을 확인하고 관리하는 데 중요한 역할을 하고 있습니다. 이 과정은 HCV RNA 또는 항체를 검출하여 조기 개입 및 치료를 가능하게 합니다. 핵산 및 효소면역측정법을 포함한 첨단 진단 기술은 정확하고 종합적인 검사를 가능하게 하여 간 관련 합병증을 줄이기 위한 공중보건 전략의 핵심이 되고 있습니다.

HCV 검사 시장은 C형 간염의 유병률 증가, 진단 기술의 발전, 적극적인 의료 대책에 힘입어 큰 성장이 예상됩니다. 주요 기업들의 전략적 노력과 조기 발견에 대한 집중으로 HCV 감염증을 관리하기 위한 효과적인 솔루션이 전 세계적으로 제공되어 시장을 견인할 것으로 예상됩니다. 지속적인 발전으로 이 시장은 세계 헬스케어에서 중요한 역할을 할 것으로 예상됩니다.

세계의 C형 간염 바이러스(HCV) 검사 시장에 대해 조사했으며, 시장 개요와 함께 기술별, 검사 유형별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 2024년 가격 분석

제4장 세계의 C형 간염 바이러스(HCV) 검사 시장 전망, 2019-2032년

• 세계의 C형 간염 바이러스(HCV) 검사 시장 전망, 기법별, 금액(10억 달러), 수량(건), 2019-2032년
• 세계의 C형 간염 바이러스(HCV) 검사 시장 전망, 검사 유형별, 가치(10억 달러), 2019-2032년
• 세계의 C형 간염 바이러스(HCV) 검사 시장 전망, 최종사용자별, 가치(10억 달러), 2019-2032년
• 세계의 C형 간염 바이러스(HCV) 검사 시장 전망, 지역별, 가치(10억 달러), 수량(건), 2019-2032년

제5장 북미의 C형 간염 바이러스(HCV) 검사 시장 전망, 2019-2032년

제6장 유럽의 C형 간염 바이러스(HCV) 검사 시장 전망, 2019-2032년

제7장 아시아태평양의 C형 간염 바이러스(HCV) 검사 시장 전망, 2019-2032년

제8장 라틴아메리카의 C형 간염 바이러스(HCV) 검사 시장 전망, 2019-2032년

제9장 중동 및 아프리카의 C형 간염 바이러스(HCV) 검사 시장 전망, 2019-2032년

제10장 경쟁 구도

• 기업 시장 점유율 분석, 2024년
• 경쟁 대시보드
• 기업 개요
  • OraSure Technologies, Inc.
  • Abbott Laboratories Inc.
  • Siemens Healthcare GmbH
  • Bio Rad Laboratories Inc.
  • Ortho Clinical Diagnostic Inc.(Johnson & Johnson)
  • Bayer AG
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • BioGenex
  • AccuQuick,
  • Roche Diagnostics(F. Hoffman-La Roche Ltd.)
  • STD Rapid Test Kits

제11장 부록

영문목차

The global Hepatitis C Virus (HCV) testing market is witnessing consistent growth, fueled by rising awareness, advancements in diagnostic technologies, and active healthcare initiatives. By 2025, the market is expected to reach 894 million, with projections indicating a rise to 1,326.7 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.80%.

Market Overview HCV testing plays a vital role in identifying and managing Hepatitis C infections, a major global health concern. The process involves detecting HCV RNA or antibodies, enabling early intervention and treatment. Advanced diagnostic techniques, including nucleic acid and enzyme immunoassays, ensure accurate and comprehensive testing, making it a cornerstone in public health strategies to reduce liver-related complications.

The HCV testing market is poised for significant growth, driven by the rising prevalence of Hepatitis C, advancements in diagnostic technologies, and proactive healthcare measures. Strategic actions by major players and a focus on early detection are expected to drive the market forward, providing effective solutions for managing HCV infections globally. With continuous advancements, the market is positioned to play a critical role in global healthcare.

Key Market Drivers

• 1. Increasing Hepatitis C Prevalence: The global rise in Hepatitis C infections has heightened the demand for accurate diagnostic methods. High-risk groups, such as individuals exposed to unsafe medical practices and intravenous drug users, underscore the importance of effective testing solutions.
• 2. Technological Innovations: Breakthroughs in diagnostic technology, such as polymerase chain reaction (PCR) and advanced immunoassays, have improved the sensitivity and accuracy of HCV testing, encouraging wider adoption.
• 3. Government and Awareness Campaigns: Efforts by governments and healthcare organizations to combat infectious diseases have boosted the uptake of HCV testing. Awareness programs highlighting early detection and treatment further drive market growth.

Opportunities for Growth The shift towards preventive healthcare and routine screenings creates lucrative opportunities for market participants. Increased investment in public health campaigns has made HCV testing a standard part of health evaluations, expanding its accessibility. Additionally, the adoption of point-of-care testing (POCT) technologies offers faster and more convenient diagnostic options in various healthcare settings.

Regional Insights

• 1. Asia Pacific: This region holds the largest market share, driven by a large population base and significant prevalence of Hepatitis C infections. Enhanced healthcare infrastructure and supportive government initiatives further fuel market growth.
• 2. Middle East & Africa: Expected to grow the fastest, this region faces unique infectious disease challenges. Investments in healthcare infrastructure and early diagnostic initiatives are fostering market expansion.
• 3. North America and Europe: These regions exhibit steady growth due to advanced healthcare systems, widespread adoption of diagnostic technologies, and heightened public awareness.

Leading Market Players Key companies shaping the HCV testing market include:

• Abbott Laboratories Inc.
• Siemens Healthcare GmbH
• Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
• Bio-Rad Laboratories Inc.
• OraSure Technologies, Inc.
• Bayer AG
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Ortho Clinical Diagnostics Inc. (Johnson & Johnson)

These industry leaders employ strategies such as technological advancements, strategic partnerships, and awareness campaigns to strengthen their market positions. For instance, Abbott Laboratories' ARCHITECT anti-HCV immunoassay and Roche Diagnostics' PCR-based assays highlight their dedication to providing precise and reliable diagnostic solutions.

Market Segmentation

1. By Technique:

Immunoassays-based Hepatitis C Virus Testing Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing Other Testing Techniques

2. By Test Type:

HCV Antibody Testing HCV Viral Load Testing HCV Genotyping Testing

3. By End User:

Hospitals Diagnostic Centers Blood Donation Centers

4. By Region:

North America Europe Asia Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Hepatitis C virus (HCV) Testing Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume (Units), 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Price Analysis, 2024

• 3.1. Global Average Price Analysis, by Technique, US$ Per Unit, 2019 - 2023
• 3.2. Prominent Factor Affecting Hepatitis C virus (HCV) Testing Prices
• 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

• 4.1. Global Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Immunoassays-based Hepatitis C Virus Testing
    • 4.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
    • 4.1.1.3. Other Hepatitis C Virus Testing Techniques
• 4.2. Global Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. HCV Antibody Testing
    • 4.2.1.2. HCV Viral Load Testing
    • 4.2.1.3. HCV Genotyping Testing
• 4.3. Global Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. Hospitals
    • 4.3.1.2. Diagnostic Centers
    • 4.3.1.3. Blood Donation Centers
• 4.4. Global Hepatitis C virus (HCV) Testing Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 4.4.1. Key Highlights
    • 4.4.1.1. North America
    • 4.4.1.2. Europe
    • 4.4.1.3. Asia Pacific
    • 4.4.1.4. Latin America
    • 4.4.1.5. Middle East & Africa

5. North America Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

• 5.1. North America Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Immunoassays-based Hepatitis C Virus Testing
    • 5.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
    • 5.1.1.3. Other Hepatitis C Virus Testing Techniques
• 5.2. North America Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. HCV Antibody Testing
    • 5.2.1.2. HCV Viral Load Testing
    • 5.2.1.3. HCV Genotyping Testing
• 5.3. North America Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. Hospitals
    • 5.3.1.2. Diagnostic Centers
    • 5.3.1.3. Blood Donation Centers
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis
• 5.4. North America Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 5.4.1. Key Highlights
    • 5.4.1.1. U.S. Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1.2. U.S. Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.3. U.S. Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 5.4.1.4. Canada Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1.5. Canada Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 5.4.1.6. Canada Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
  • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

• 6.1. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Immunoassays-based Hepatitis C Virus Testing
    • 6.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
    • 6.1.1.3. Other Hepatitis C Virus Testing Techniques
• 6.2. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. HCV Antibody Testing
    • 6.2.1.2. HCV Viral Load Testing
    • 6.2.1.3. HCV Genotyping Testing
• 6.3. Europe Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Hospitals
    • 6.3.1.2. Diagnostic Centers
    • 6.3.1.3. Blood Donation Centers
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis
• 6.4. Europe Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 6.4.1. Key Highlights
    • 6.4.1.1. Germany Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1.2. Germany Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.3. Germany Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.1.4. U.K. Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1.5. U.K. Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.6. U.K. Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.1.7. France Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1.8. France Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.9. France Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.1.10. Italy Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1.11. Italy Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.12. Italy Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.1.13. Turkey Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1.14. Turkey Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.15. Turkey Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.1.16. Russia Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1.17. Russia Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.18. Russia Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 6.4.1.19. Rest of Europe Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1.20. Rest of Europe Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 6.4.1.21. Rest of Europe Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
  • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

• 7.1. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Immunoassays-based Hepatitis C Virus Testing
    • 7.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
    • 7.1.1.3. Other Hepatitis C Virus Testing Techniques
• 7.2. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. HCV Antibody Testing
    • 7.2.1.2. HCV Viral Load Testing
    • 7.2.1.3. HCV Genotyping Testing
• 7.3. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. Hospitals
    • 7.3.1.2. Diagnostic Centers
    • 7.3.1.3. Blood Donation Centers
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis
• 7.4. Asia Pacific Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 7.4.1. Key Highlights
    • 7.4.1.1. China Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1.2. China Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.3. China Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 7.4.1.4. Japan Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1.5. Japan Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.6. Japan Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 7.4.1.7. South Korea Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1.8. South Korea Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.9. South Korea Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 7.4.1.10. India Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1.11. India Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.12. India Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 7.4.1.13. Southeast Asia Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1.14. Southeast Asia Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.15. Southeast Asia Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 7.4.1.16. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1.17. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 7.4.1.18. Rest of Asia Pacific Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
  • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

• 8.1. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Immunoassays-based Hepatitis C Virus Testing
    • 8.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
    • 8.1.1.3. Other Hepatitis C Virus Testing Techniques
• 8.2. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. HCV Antibody Testing
    • 8.2.1.2. HCV Viral Load Testing
    • 8.2.1.3. HCV Genotyping Testing
• 8.3. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Hospitals
    • 8.3.1.2. Diagnostic Centers
    • 8.3.1.3. Blood Donation Centers
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis
• 8.4. Latin America Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 8.4.1. Key Highlights
    • 8.4.1.1. Brazil Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1.2. Brazil Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.3. Brazil Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 8.4.1.4. Mexico Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1.5. Mexico Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.6. Mexico Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 8.4.1.7. Argentina Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1.8. Argentina Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.9. Argentina Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 8.4.1.10. Rest of Latin America Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1.11. Rest of Latin America Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 8.4.1.12. Rest of Latin Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
  • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, 2019 - 2032

• 9.1. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Immunoassays-based Hepatitis C Virus Testing
    • 9.1.1.2. Polymerase Chain Reaction-based (PCR) Hepatitis C Virus Testing
    • 9.1.1.3. Other Hepatitis C Virus Testing Techniques
• 9.2. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Test Type, Value (US$ Bn, 2019 - 2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. HCV Antibody Testing
    • 9.2.1.2. HCV Viral Load Testing
    • 9.2.1.3. HCV Genotyping Testing
• 9.3. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by End-user, Value (US$ Bn, 2019 - 2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. Hospitals
    • 9.3.1.2. Diagnostic Centers
    • 9.3.1.3. Blood Donation Centers
  • 9.3.2. BPS Analysis/Market Attractiveness Analysis
• 9.4. Middle East & Africa Hepatitis C virus (HCV) Testing Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 9.4.1. Key Highlights
    • 9.4.1.1. GCC Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1.2. GCC Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 9.4.1.3. GCC Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 9.4.1.4. South Africa Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1.5. South Africa Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 9.4.1.6. South Africa Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 9.4.1.7. Egypt Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1.8. Egypt Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 9.4.1.9. Egypt Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 9.4.1.10. Nigeria Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1.11. Nigeria Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 9.4.1.12. Nigeria Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
    • 9.4.1.13. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by Technique, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1.14. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by Test Type, Value (US$ Bn), 2019 - 2032
    • 9.4.1.15. Rest of Middle East & Africa Hepatitis C virus (HCV) Testing Market by End-user, Value (US$ Bn), 2019 - 2032
  • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

• 10.1. Company Market Share Analysis, 2024
• 10.2. Competitive Dashboard
• 10.3. Company Profiles
  • 10.3.1. OraSure Technologies, Inc.
    • 10.3.1.1. Company Overview
    • 10.3.1.2. Technique Portfolio
    • 10.3.1.3. Financial Overview
    • 10.3.1.4. Business Strategies and Development
  • 10.3.2. Abbott Laboratories Inc.
    • 10.3.2.1. Company Overview
    • 10.3.2.2. Technique Portfolio
    • 10.3.2.3. Financial Overview
    • 10.3.2.4. Business Strategies and Development
  • 10.3.3. Siemens Healthcare GmbH
    • 10.3.3.1. Company Overview
    • 10.3.3.2. Technique Portfolio
    • 10.3.3.3. Financial Overview
    • 10.3.3.4. Business Strategies and Development
  • 10.3.4. Bio Rad Laboratories Inc.
    • 10.3.4.1. Company Overview
    • 10.3.4.2. Technique Portfolio
    • 10.3.4.3. Financial Overview
    • 10.3.4.4. Business Strategies and Development
  • 10.3.5. Ortho Clinical Diagnostic Inc. (Johnson & Johnson)
    • 10.3.5.1. Company Overview
    • 10.3.5.2. Technique Portfolio
    • 10.3.5.3. Financial Overview
    • 10.3.5.4. Business Strategies and Development
  • 10.3.6. Bayer AG
    • 10.3.6.1. Company Overview
    • 10.3.6.2. Technique Portfolio
    • 10.3.6.3. Financial Overview
    • 10.3.6.4. Business Strategies and Development
  • 10.3.7. QIAGEN N.V.
    • 10.3.7.1. Company Overview
    • 10.3.7.2. Technique Portfolio
    • 10.3.7.3. Financial Overview
    • 10.3.7.4. Business Strategies and Development
  • 10.3.8. Thermo Fisher Scientific Inc.
    • 10.3.8.1. Company Overview
    • 10.3.8.2. Technique Portfolio
    • 10.3.8.3. Financial Overview
    • 10.3.8.4. Business Strategies and Development
  • 10.3.9. BioGenex
    • 10.3.9.1. Company Overview
    • 10.3.9.2. Technique Portfolio
    • 10.3.9.3. Financial Overview
    • 10.3.9.4. Business Strategies and Development
  • 10.3.10. AccuQuick,
    • 10.3.10.1. Company Overview
    • 10.3.10.2. Technique Portfolio
    • 10.3.10.3. Financial Overview
    • 10.3.10.4. Business Strategies and Development
  • 10.3.11. Roche Diagnostics (F. Hoffman-La Roche Ltd.)
    • 10.3.11.1. Company Overview
    • 10.3.11.2. Technique Portfolio
    • 10.3.11.3. Financial Overview
    • 10.3.11.4. Business Strategies and Development
  • 10.3.12. STD Rapid Test Kits
    • 10.3.12.1. Company Overview
    • 10.3.12.2. Technique Portfolio
    • 10.3.12.3. Financial Overview
    • 10.3.12.4. Business Strategies and Development

11. Appendix

• 11.1. Research Methodology
• 11.2. Report Assumptions
• 11.3. Acronyms and Abbreviations